Tocilizumab in COVID-19: Beware the risk of intestinal perforation
Jens Vikse, Brandon Michael Henry
Topics & Concepts
Coronavirus disease 2019 (COVID-19)TocilizumabMedicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PerforationPandemicInternal medicineVirologyOutbreakInfectious disease (medical specialty)MetallurgyMaterials scienceDiseasePunchingCOVID-19 Clinical Research StudiesDental Research and COVID-19COVID-19 and healthcare impacts